Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Vet Pathol ; 52(6): 1052-6, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25445321

ABSTRACT

To investigate the molecular mechanisms of the oncogenic effects of avian leukosis virus subgroup J (ALV-J), we examined mutations in and the expression of p53 in the myelocytomas distributed in the liver, spleen, trachea, and bone marrow, as well as in fibrosarcomas in the abdominal cavity and hemangiomas in skin from chickens that were naturally or experimentally infected with ALV-J. Two types of mutations in the p53 gene were detected in myelocytomas of both the experimentally infected and the naturally infected chickens and included point mutations and deletions. Two of the point mutations have not been reported previously. Partial complementary DNA clones with a 122-bp deletion in the p53 gene ORF and a 15-bp deletion in the C-terminus were identified in the myelocytomas. In addition, moderate expression of the mutant p53 protein was detected in the myelocytomas that were distributed in the liver, trachea, spleen, and bone marrow. Mutant p53 protein was not detected in the subcutaneous hemangiomas or in the abdominal fibrosarcomas associated with natural and experimental ALV-J infection, respectively. These results identify mutations associated with abnormal expression of p53 in ALV-J-associated myelocytomas, suggesting a role in tumorigenesis.


Subject(s)
Avian Leukosis Virus/pathogenicity , Avian Leukosis/complications , Chickens/virology , Hemangioma/veterinary , Poultry Diseases/pathology , Tumor Suppressor Protein p53/genetics , Animals , Avian Leukosis/virology , Avian Leukosis Virus/isolation & purification , Female , Hemangioma/pathology , Mutation , Poultry Diseases/virology , Specific Pathogen-Free Organisms
2.
Phys Rev Lett ; 112(5): 056402, 2014 Feb 07.
Article in English | MEDLINE | ID: mdl-24580616

ABSTRACT

We synthesize and study single crystals of a new double-perovskite Sr2YIrO6. Despite two strongly unfavorable conditions for magnetic order, namely, pentavalent Ir5+(5d4) ions which are anticipated to have Jeff=0 singlet ground states in the strong spin-orbit coupling (SOC) limit and geometric frustration in a face-centered cubic structure formed by the Ir5+ ions, we observe this iridate to undergo a novel magnetic transition at temperatures below 1.3 K. We provide compelling experimental and theoretical evidence that the origin of magnetism is in an unusual interplay between strong noncubic crystal fields, local exchange interactions, and "intermediate-strength" SOC. Sr2YIrO6 provides a rare example of the failed dominance of SOC in the iridates.

3.
J Phys Condens Matter ; 24(34): 345601, 2012 Aug 29.
Article in English | MEDLINE | ID: mdl-22850526

ABSTRACT

We report an experimental/theoretical study of single-crystal Bi(2)Ir(2)O(7) that possesses a metallic state with strongly exchange-enhanced paramagnetism. The ground state of Bi(2)Ir(2)O(7) is characterized by the following features: (1) a divergent low-temperature magnetic susceptibility that indicates no long-range order down to 50 mK; (2) strongly field-dependent coefficients of the low-temperature T and T(3) terms of the specific heat; (3) a conspicuously large Wilson ratio R(W) ≈ 53.5; and (4) unusual temperature and field dependences of the Hall resistivity that abruptly change below 80 K, without any clear correlation with the magnetic behavior. All these unconventional properties suggest the existence of an exotic ground state in Bi(2)Ir(2)O(7).

4.
Phys Rev Lett ; 100(1): 016604, 2008 Jan 11.
Article in English | MEDLINE | ID: mdl-18232800

ABSTRACT

The spin-valve effect is a quantum phenomenon so far only realized in multilayer thin films or heterostructures. Here we report a strong spin-valve effect existing in bulk single crystals of Ca3(Ru1-xCrx)2O7 having an anisotropic, bilayered crystal structure. This discovery opens new avenues to understand the underlying physics of spin valves, and fully realize its potential in practical devices.

5.
Genes Dev ; 12(10): 1425-37, 1998 May 15.
Article in English | MEDLINE | ID: mdl-9585503

ABSTRACT

Receptor tyrosine phosphatases have been implicated in playing important roles in cell signaling events by their ability to regulate the level of protein tyrosine phosphorylation. Although the catalytic activity of their phosphatase domains has been well established, the biological roles of these molecules are, for the most part, not well understood. Here we show that the Caenorhabditis elegans protein CLR-1 (CLeaR) is a receptor tyrosine phosphatase (RTP) with a complex extracellular region and two intracellular phosphatase domains. Mutations in clr-1 result in a dramatic Clr phenotype that we have used to study the physiological requirements for the CLR-1 RTP. We show that the phosphatase activity of the membrane-proximal domain is essential for the in vivo function of CLR-1. By contrast, we present evidence that the membrane-distal domain is not required to prevent the Clr phenotype in vivo. The Clr phenotype of clr-1 mutants is mimicked by activation of the EGL-15 fibroblast growth factor receptor (FGFR) and is suppressed by mutations that reduce or eliminate the activity of egl-15. Our data strongly indicate that CLR-1 attenuates the action of an FGFR-mediated signaling pathway by dephosphorylation.


Subject(s)
Caenorhabditis elegans Proteins , Caenorhabditis elegans/physiology , Genes, Helminth , Helminth Proteins/physiology , Protein Processing, Post-Translational , Protein Tyrosine Phosphatases/physiology , Receptors, Fibroblast Growth Factor/physiology , Signal Transduction/physiology , Alleles , Amino Acid Sequence , Animals , COS Cells , Caenorhabditis elegans/genetics , Chromosomes, Artificial, Yeast , Consensus Sequence , DNA, Complementary/genetics , DNA, Helminth/genetics , Escherichia coli , Genes, Suppressor , Genetic Heterogeneity , Helminth Proteins/genetics , Molecular Sequence Data , Phenotype , Phosphorylation , Protein Tyrosine Phosphatases/genetics , Receptor-Like Protein Tyrosine Phosphatases , Receptors, Fibroblast Growth Factor/genetics , Recombinant Fusion Proteins/metabolism , Sequence Alignment , Sequence Homology, Amino Acid , Signal Transduction/genetics , Structure-Activity Relationship , Temperature , Transfection
6.
Biophys J ; 70(3): 1466-71, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8785303

ABSTRACT

Previous work from this laboratory demonstrated that the environment-sensitive lysolipid N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)- monomyristoylphosphatidylethanolamine (N-NBD-MPE), at concentrations below its critical micelle concentration (CMCN-NBD-MPE = 4 microM), reached maximum fluorescence yield upon the addition of taurodeoxycholate (TDC) at concentrations well below its CMC (CMCTDC = 2.5 mM). These data indicated the formation of micellar aggregates of the two amphiphiles at concentrations below both of their CMCs. In the present study, fluorescence lifetime and differential polarization measurements were made to determine the size of these aggregates. In the absence of TDC and at 0.5 mM TDC a single lifetime (tau) and rotational correlation time (phi) were measured for N-NBD-MPE at the submicellar concentration of 2 microM, indicating a lack of interaction between the two molecules at this concentration. Above 0.5 mM TDC, two discrete lifetimes were resolved. Based on these lifetimes, two distinct rotational correlation times were established through polarization measurements. The shorter phi(0.19-0.73 ns) was ascribed to local probe motions, whereas the longer phi was in a time range expected for global rotation of aggregates the size of simple bile salt micelles (3-6.5 ns). From the longer phi, molecular volume and hydrodynamic radii were calculated, ranging from approximately 15 A at 1 mM to approximately 18 A at 5 mM TDC. These data support the conclusion that monomeric lysolipids in solution seed the aggregation of numerous TDC molecules (aggregation number = 16 at 1 mM TDC) to form a TDC micelle with a lysolipid core at concentrations below which they both self-aggregate.


Subject(s)
Fluorescent Dyes/chemistry , Lysophospholipids/chemistry , Phosphatidylethanolamines/chemistry , Taurodeoxycholic Acid/chemistry , Biophysical Phenomena , Biophysics , Fluorescence Polarization , In Vitro Techniques , Macromolecular Substances , Micelles , Molecular Structure , Solutions
7.
Biophys J ; 64(6): 1750-9, 1993 Jun.
Article in English | MEDLINE | ID: mdl-8369405

ABSTRACT

A number of studies have indicated that Ca(2+)-ATPase, the integral membrane protein of the sarcoplasmic reticulum (SR) membrane, undergoes some structural change upon Ca2+ binding to its high affinity binding sites (i.e., upon conversion of the E1 to the CaxE1 form of the enzyme). We have used x-ray diffraction to study the changes in the electron density profile of the SR membrane upon high-affinity Ca2+ binding to the enzyme in the absence of enzyme phosphorylation. The photolabile Ca2+ chelator DM-nitrophen was used to rapidly release Ca2+ into the extravesicular spaces throughout an oriented SR membrane multilayer and thereby synchronously in the vicinity of the high affinity binding sites of each enzyme molecule in the multilayer. A critical control was developed to exclude possible artifacts arising from heating and non-Ca2+ photolysis products in the membrane multilayer specimens upon photolysis of the DM-nitrophen. Upon photolysis, changes in the membrane electron density profile arising from high-affinity Ca2+ binding to the enzyme are found to be localized to three different regions within the profile. These changes can be attributed to the added electron density of the Ca2+ bound at three discrete sites centered at 5, approximately 30, and approximately 67 A in the membrane profile, but they also require decreased electron density within the cylindrically averaged profile structure of the Ca(2+)-ATPase immediately adjacent (< 15 A) to these sites. The locations of these three Ca2+ binding sites in the SR membrane profile span most of the membrane profile in the absence of enzyme phosphorylation,in agreement with the locations of lanthanide (Tb3+ and La3+) binding sites in the membrane profile determined independently by using resonance x-ray diffraction.


Subject(s)
Calcium-Transporting ATPases/metabolism , Calcium/metabolism , Sarcoplasmic Reticulum/ultrastructure , Animals , Binding Sites , Calcium/pharmacology , Calcium-Transporting ATPases/chemistry , Kinetics , Models, Structural , Photolysis , Protein Conformation , Sarcoplasmic Reticulum/drug effects , Sarcoplasmic Reticulum/enzymology , X-Ray Diffraction/methods
8.
Genetics ; 133(4): 875-96, 1993 Apr.
Article in English | MEDLINE | ID: mdl-8462848

ABSTRACT

In Caenorhabditis elegans, sex determination and dosage compensation are coordinately controlled through a group of genes that respond to the primary sex determination signal. Here we describe a new gene, sdc-3, that also controls these processes. In contrast to previously described genes, the sex determination and dosage compensation activities of sdc-3 are separately mutable, indicating that they function independently. Paradoxically, the sdc-3 null phenotype fails to reveal the role of sdc-3 in sex determination: sdc-3 null mutations that lack both activities disrupt dosage compensation but cause no overt sexual transformation. We demonstrate that the dosage compensation defect of sdc-3 null alleles suppresses their sex determination defect. This self-suppression phenomenon provides a striking example of how a disruption in dosage compensation can affect sexual fate. We propose that the suppression occurs via a feedback mechanism that acts at an early regulatory step in the sex determination pathway to promote proper sexual identity.


Subject(s)
Caenorhabditis elegans Proteins , Caenorhabditis elegans/genetics , DNA-Binding Proteins , Dosage Compensation, Genetic , Helminth Proteins/genetics , Sex Determination Analysis , Alleles , Animals , Feedback , Female , Genes, Regulator , Male , Mutation , Phenotype , RNA, Messenger/genetics , X Chromosome
11.
J Biochem Biophys Methods ; 21(4): 333-9, 1990.
Article in English | MEDLINE | ID: mdl-2150968

ABSTRACT

The kinetics of Ca2+ binding to the high-affinity sites of the sarcoplasmic reticulum (SR) Ca2(+)-ATPase were directly investigated by continuously monitoring the extravesicular calcium concentration via the metallochromic indicator Arsenazo III following the release of Ca2+ from a photolabile caged-calcium molecule, 1-(2-nitro-4,5-dimethoxyphenyl)-N,N,N',N'-tetrakis [(oxycarbony)methyl]-1,2-ethanediamine (DM-nitrophen), utilizing a pulsed Nd:YAG laser for photolysis. The nature of the binding kinetics is at least biphasic over the first 400 ms for vesicular dispersions of SR. The stoichiometry for calcium binding expressed as Ca:E1 approximately P has been calculated to be approximately 1.4:1 for the pure SR preparation under the reaction conditions employed.


Subject(s)
Calcium-Transporting ATPases/metabolism , Calcium/metabolism , Photolysis , Sarcoplasmic Reticulum/metabolism , Acetates , Animals , Chelating Agents , Ethylenediamines , Kinetics , Protein Binding , Rabbits
12.
Genetics ; 121(1): 57-76, 1989 Jan.
Article in English | MEDLINE | ID: mdl-2917714

ABSTRACT

We report a genetic characterization of several essential components of the dosage compensation process in Caenorhabditis elegans. Mutations in the genes dpy-26, dpy-27, dpy-28, and the newly identified gene dpy-29 disrupt dosage compensation, resulting in elevated X-linked gene expression in XX animals and an incompletely penetrant maternal-effect XX-specific lethality. These dpy mutations appear to cause XX animals to express each set of X-linked genes at a level appropriate for XO animals. XO dpy animals are essentially wild type. Both the viability and the level of X-linked gene expression in XX animals carrying mutations in two or more dpy genes are the same as in animals carrying only a single mutation, consistent with the view that these genes act together in a single process (dosage compensation). To define a potential time of action for the gene dpd-28 we performed reciprocal temperature-shift experiments with a heat sensitive allele. The temperature-sensitive period for lethality begins 5 hr after fertilization at the 300-cell stage and extends to about 9 hr, a point well beyond the end of cell proliferation. This temperature-sensitive period suggests that dosage compensation is functioning in XX animals by mid-embryogenesis, when many zygotically transcribed genes are active. While mutations in the dpy genes have no effect on the sexual phenotype of otherwise wild-type XX or XO animals, they do have a slight feminizing effect on animals whose sex-determination process is already genetically perturbed. The opposite directions of the feminizing effects on sex determination and the masculinizing effects on dosage compensation caused by the dpy mutations are inconsistent with the wild-type dpy genes acting to coordinately control both processes. Instead, the feminizing effects are most likely an indirect consequence of disruptions in dosage compensation caused by the dpy mutations. Based on the cumulative evidence, the likely mechanism of dosage compensation in C. elegans involves reducing X-linked gene expression in XX animals to equal that in XO animals via the action of the dpy genes.


Subject(s)
Caenorhabditis/genetics , Disorders of Sex Development/genetics , Dosage Compensation, Genetic , Genes, Regulator , Animals , Caenorhabditis/embryology , Chromosome Mapping , Genes, Lethal , Genetic Linkage , Genotype , Models, Genetic , Mutation , Nondisjunction, Genetic , Suppression, Genetic , Temperature , X Chromosome
13.
Genetics ; 117(4): 657-70, 1987 Dec.
Article in English | MEDLINE | ID: mdl-3428573

ABSTRACT

Caenorhabditis elegans compensates for the difference in X chromosome gene dose between males (XO) and hermaphrodites (XX) through a mechanism that equalizes the levels of X-specific mRNA transcripts between the two sexes. We have devised a sensitive and quantitative genetic assay to measure perturbations in X chromosome gene expression caused by mutations that affect this process of dosage compensation. The assay is based on quantitating the precocious alae phenotype caused by a mutation that reduces but does not eliminate the function of the X-linked gene lin-14. We demonstrate that in diploid animals the lin-14 gene is dosage compensated, implying that the normal dosage compensation mechanism in C. elegans lacks the capacity to compensate completely for the additional X chromosome in triplo-X animals. Using the lin-14 assay we compare the effects of mutations in the genes dpy-21, dpy-26, dpy-27, dpy-28, and dpy-22 on X-linked gene expression. Additionally, in the case of dpy-21 we correlate the change in phenotypic expression of lin-14 with a corresponding change in the lin-14 mRNA transcript level.


Subject(s)
Caenorhabditis/genetics , X Chromosome , Animals , Disorders of Sex Development , Female , Male , Mutation , Phenotype
SELECTION OF CITATIONS
SEARCH DETAIL
...